openPR Logo
Press release

Pneumonia Market Size, Epidemiology Trends, Treatment, and Forecast to 2035

06-06-2025 10:21 AM CET | Health & Medicine

Press release from: IMARC Group

Pneumonia Market Size, Epidemiology Trends, Treatment, and Forecast to 2035

Pneumonia Market Size, Epidemiology Trends, Treatment, and Forecast to 2035

According to the latest report by IMARC Group, the top 7 (US, EU4, UK, and Japan) pneumonia markets are expected to exhibit a CAGR of 5.16% during 2025-2035.

The pneumonia market is witnessing significant growth, driven by the advances in diagnostics, treatment, and prevention. Pneumonia forms one of the main causes of illness and death worldwide, affecting vulnerable groups such as children under five and the elderly. Increased incidence of pneumonia and increased healthcare awareness are reacting to increased demand for its treatment and prevention.

One of the other few factors driving demand is the development and adoption of advanced diagnostic tools. Rapid diagnostic tests and molecular assays have revolutionized pneumonia detection by providing quick and accurate diagnosis and, consequently, timely treatment. These advances are particularly useful in resource-limited settings since early diagnosis can substantially reduce the burden of complications and their associated healthcare costs.

Request for a sample of this report: https://www.imarcgroup.com/pneumonia-market/requestsample

Another evolving area of therapeutics for pneumonia is antibiotic therapy with respect to the developing issues on antibiotic resistance. This will guarantee that bacterial pneumonia will be kept to a minimum. On the other hand, support therapies like oxygen supplementation and physiotherapy work wonders in enhancing patient recovery and outcomes.

Further backing of the market comes from pneumonia cases increasing among immunocompromised patients, either with chronic diseases or those receiving treatments that are immunosuppressive in nature. This particular population requires specialized treatment regimes and continued monitoring, therefore, providing a stimulus to the said market for healthcare services for pneumonia.

The evolution of telemedicine and digital health platforms has improved access to pneumonia care in underserved and far-flung areas. These platforms allow virtual consultations, remote monitoring, and timely medical advice to promote continuity of care and to reduce hospital admissions.

Ask the Analyst for Customization and Get Full Insights with TOC: https://www.imarcgroup.com/request?type=report&id=8133&flag=E

This report also provides a detailed analysis of the current pneumonia marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Countries Covered

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Competitive Landscape With Key Players:

The competitive landscape of the pneumonia market has been studied in the report with the detailed profiles of the key players operating in the market.

AbbVie
Merck & Co., Inc.
Shionogi Inc.
Paratek Pharmaceuticals, Inc.
Nabriva Therapeutics plc
APTARION Biotech AG
Biotest AG

IMARC Group Offers Other Reports:

Type 2 Diabetes Market:https://www.imarcgroup.com/type-2-diabetes-market

Klebsiella Pneumoniae Infections Market: https://www.imarcgroup.com/klebsiella-pneumoniae-infections-market

Hand Eczema Market:https://www.imarcgroup.com/hand-eczema-market

Cardiotoxicity Market:https://www.imarcgroup.com/cardiotoxicity-market

Inflammatory Bowel Disease Market:https://www.imarcgroup.com/inflammatory-bowel-disease-market

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumonia Market Size, Epidemiology Trends, Treatment, and Forecast to 2035 here

News-ID: 4054802 • Views: …

More Releases from IMARC Group

Supercapacitor Market Size to Reach $31.07B by 2033: Trends & Opportunities
Supercapacitor Market Size to Reach $31.07B by 2033: Trends & Opportunities
Market Overview: The supercapacitor market is experiencing rapid growth, driven by electrification of automotive systems, renewable energy and grid stabilization, and expansion of industrial automation and robotics. According to IMARC Group's latest research publication, "Supercapacitor Market Size, Share, Trends and Forecast by Product Type, Module Type, Material Type, End Use Industry, and Region, 2025-2033", the global supercapacitor market size was valued at USD 6.41 Billion in 2024. Looking forward, IMARC Group…
Bicycle Market Size to Surpass $102.05B by 2033: Growth & Insights
Bicycle Market Size to Surpass $102.05B by 2033: Growth & Insights
Market Overview: The bicycle market is experiencing rapid growth, driven by global expansion of cycling infrastructure, rising health consciousness and preventative wellness, and technological advancements in e-bike propulsion. According to IMARC Group's latest research publication, "Bicycle Market Size, Share, Trends and Forecast by Type, Technology, Price, Distribution Channel, End User, and Region, 2025-2033", The global bicycle market size was valued at USD 67.42 Billion in 2024. Looking forward, IMARC Group estimates…
Baby Food and Infant Formula Market to Reach USD 84.06 Billion by 2033, Growing at a CAGR of 4.58%
Baby Food and Infant Formula Market to Reach USD 84.06 Billion by 2033, Growing …
Market Overview: The Baby Food and Infant Formula Market is experiencing steady expansion, driven by Increasing Awareness of Nutritional Needs for Infants, Rising Number of Working Women, and Technological Advancements and Product Innovation. According to IMARC Group's latest research publication, "Baby Food and Infant Formula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global baby food and infant formula market size reached USD 53.73 Billion in 2024.…
Breakfast Cereals Market to Reach USD 149.07 Billion by 2033, Growing at a CAGR of 3.55%
Breakfast Cereals Market to Reach USD 149.07 Billion by 2033, Growing at a CAGR …
Market Overview: The Breakfast Cereals Market is experiencing rapid growth, driven by Health and Wellness Awareness, Busy Lifestyles and On-the-Go Demand and Rising Disposable Incomes and Global Market Expansion . According to IMARC Group's latest research publication, "Breakfast Cereals Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global breakfast cereals market size was valued at USD 108.89 Billion in 2024. Looking forward, IMARC Group estimates…

All 5 Releases


More Releases for Pneumonia

Nosocomial pneumonia, which is acquired in hospitals, and pneumonia linked to ve …
Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a severe lung infection that develops 48 hours or more after hospital admission, often associated with invasive procedures such as mechanical ventilation. It is one of the most common healthcare-associated infections, contributing significantly to morbidity, mortality, and healthcare costs. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72903 With the rise of antibiotic resistance, aging populations, and increased use of ventilators in…
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776 Key Market Drivers • Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market? The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills. Read Report Overview -…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview: The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH.  Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market.  Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…